Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
NCT00706368 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2008-06-27
Summary
Symptoms of vaginitis are common among adolescent females, although studies have shown that neither experienced clinicians nor patients can accurately diagnose the cause of vaginitis based on symptoms alone. The purpose of this study is to investigate the accuracy and acceptability of self-diagnostic methods for vaginitis in adolescent females.
Conditions
- Trichomonas Vaginalis
Interventions
- DEVICE
-
Point of care tests
Several point-of-care tests are offered: OSOM TV rapid trichomonas test; OSOM BV Blue rapid test; pHEMalert vaginal pH test. All subjects receive the OSOM TV test, while the other two are optional.
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Jill S Huppert, MD, MPH · Children's Hospital Medical Center, Cincinnati
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 14 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
Countries
- United States
Study Locations
More Related Trials
-
Multi-Center Study of New Medications to Treat Vaginal Infections
NCT02308007 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
NCT06983041 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
NCT02709005 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)
NCT01437722 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463
NCT01812889 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis
NCT01577238 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)
NCT03769688 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis
NCT01577537 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women
NCT03196492 ·Status: COMPLETED
-
Treatment of Bacterial Vaginosis With Oral Tinidazole
NCT00229216 ·Status: COMPLETED ·Phase: PHASE3
-
An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots
NCT00214812 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of UC-781 Vaginal Microbicide
NCT00132444 ·Status: COMPLETED ·Phase: PHASE1
-
Optical Imaging and User Perception Study of Vaginal Gel
NCT01716000 ·Status: COMPLETED ·Phase: NA
-
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
NCT04553068 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects
NCT01020877 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)
NCT02237950 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Estriol for Vaginal Health
NCT00908570 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Double-Blind Placebo-Controlled Trial to Assess Overall User Experience of a Synbiotic Vaginal Suppository
NCT06236893 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection
NCT06450990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
NCT00594373 ·Status: COMPLETED ·Phase: PHASE1
-
Suppression Of Bacterial Vaginosis (BV) [SUBVert]
NCT03930745 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Acceptability of a Vaginal Microbicide
NCT00111943 ·Status: COMPLETED ·Phase: PHASE2
-
Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention
NCT04966507 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
NCT01230814 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
NCT03091777 ·Status: COMPLETED ·Phase: PHASE3